FreedmanD. O.,
WeldL. H.,
KozarskyP. E.,
FiskT.,
RobinsR.,
von SonnenbergF.,
KeystoneJ. S.,
PandeyP.,
CetronM. S.other authors2006; Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354:119–130[CrossRef]
NkemnguN. J.,
AsonganyiE. D.,
NjundaA. L.2005; Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. BMC Infect Dis 5:49[CrossRef]
ParryC. M.2004; The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. Trans R Soc Trop Med Hyg 98:413–422[CrossRef]
RenukaK.,
SoodS.,
DasB. K.,
KapilA.2005; High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol 54:999–1000[CrossRef]
SlingerR.,
DesjardinsM.,
McCarthyA. E.,
RamotarK.,
JessamineP.,
GuibordC.,
ToyeB.2004; Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility. BMC Infect Dis 4:36[CrossRef]
WainJ.,
DiepT. S.,
HoV. A.,
WalshA. M.,
NguyenT. T.,
ParryC. M.,
WhiteN. J.1998; Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol 36:1683–1687